BERARDICURTI, ONORINA
 Distribuzione geografica
Continente #
AS - Asia 2.947
NA - Nord America 763
EU - Europa 379
SA - Sud America 125
AF - Africa 19
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.238
Nazione #
SG - Singapore 2.088
US - Stati Uniti d'America 724
CN - Cina 380
HK - Hong Kong 321
BR - Brasile 94
GB - Regno Unito 94
IT - Italia 82
DE - Germania 66
VN - Vietnam 62
IN - India 29
NL - Olanda 28
CA - Canada 27
JP - Giappone 17
FI - Finlandia 15
FR - Francia 15
ES - Italia 13
ID - Indonesia 12
AR - Argentina 10
UA - Ucraina 10
ZA - Sudafrica 10
PL - Polonia 9
TR - Turchia 9
MX - Messico 8
BD - Bangladesh 7
CO - Colombia 7
AT - Austria 6
CZ - Repubblica Ceca 6
EC - Ecuador 6
PK - Pakistan 6
SE - Svezia 6
RU - Federazione Russa 5
AU - Australia 4
BG - Bulgaria 4
IE - Irlanda 4
IL - Israele 4
LT - Lituania 4
MA - Marocco 4
LV - Lettonia 3
PY - Paraguay 3
CL - Cile 2
EE - Estonia 2
GT - Guatemala 2
PE - Perù 2
SA - Arabia Saudita 2
TL - Timor Orientale 2
AF - Afghanistan, Repubblica islamica di 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GM - Gambi 1
GY - Guiana 1
HU - Ungheria 1
IQ - Iraq 1
IS - Islanda 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 4.238
Città #
Hong Kong 320
Singapore 215
Hefei 200
Ashburn 159
Boardman 108
Dallas 91
Beijing 87
London 83
Council Bluffs 60
Shanghai 59
Munich 33
Ho Chi Minh City 28
Amsterdam 24
San Francisco 22
Rome 21
Los Angeles 20
Santa Clara 20
Pune 14
Bari 13
Toronto 13
Washington 13
Tokyo 12
Brooklyn 10
Hanoi 10
Seattle 10
São Paulo 10
New York 9
Warsaw 9
Jaguariúna 8
Turku 8
West Jordan 8
Montreal 7
Nuremberg 7
Ankara 6
Boston 6
Brno 6
Chennai 6
Helsinki 6
Chicago 5
Johannesburg 5
Mexico City 5
Stockholm 5
Atlanta 4
Dublin 4
Guangzhou 4
Haiphong 4
Jinan 4
Las Vegas 4
Noicattaro 4
Phoenix 4
Porto Alegre 4
State College 4
Buenos Aires 3
Curitiba 3
Manchester 3
Shijiazhuang 3
Sofia 3
Sydney 3
Tel Aviv 3
Anantapur 2
Augusta 2
Barcelona 2
Biên Hòa 2
Bogotá 2
Boydton 2
Brest 2
Campinas 2
Can Tho 2
Charlotte 2
Collazzone 2
Denver 2
Dili 2
Extrema 2
Florencio Varela 2
Guatemala City 2
Herne Bay 2
Hyderabad 2
Karachi 2
L'aquila 2
Madrid 2
Makkah 2
Milan 2
Naples 2
Narashino Shi 2
Newark 2
Paris 2
Poplar 2
Rabat 2
Rahim Yar Khan 2
Reus 2
Riga 2
Secaucus 2
Takatsuki Shi 2
Aioicho 1
Aleksandrovka 1
Alexandria 1
Alicante 1
Americana 1
Angra dos Reis 1
Araraquara 1
Totale 1.897
Nome #
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 206
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 196
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 189
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 171
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 123
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 112
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 98
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 95
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 94
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 87
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 87
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 85
Cytokine storm syndrome in severe COVID-19 83
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 80
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 79
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 76
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial 74
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 73
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 72
Cardiovascular disease in primary sjögren’s syndrome 67
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 66
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 62
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 57
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 51
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 50
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 48
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis 44
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis 44
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 44
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 35
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 33
Vitamin D and systemic lupus erythematosus - The hype and the hope 33
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 33
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 32
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 31
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 31
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 30
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 30
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 29
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 29
Incidence of venous thromboembolism in rheumatoid arthritis, results from a "real-life" cohort and an appraisal of available literature 28
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 28
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 28
Maladaptive Autophagy in the Pathogenesis of Autoimmune Epithelitis in Sjögren's Syndrome 28
Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren's syndrome 27
Interstitial lung disease in systemic sclerosis: current and future treatment. 27
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 27
Co-Occurrence of Anti-Synthetase Syndrome and Sjögren Disease: A Case-Based Review 26
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 26
Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patients 26
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile 26
Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interaction 26
Endothelial-to-mesenchymal transition in systemic sclerosis 25
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 24
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 24
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 24
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 24
Peripheral Nervous System Involvement in Sjögren's Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren's Syndrome 24
The clinical heterogeneity of adult onset Still's disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients 23
The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease 23
Rheumatic manifestations of COVID-19: a systematic review and meta-analysis 23
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach 23
Glucocorticoids in Rheumatoid Arthritis: The Silent Companion in the Therapeutic Strategy 23
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 23
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease 23
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry 22
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 22
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm 22
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 22
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 22
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 22
Dissecting the clinical heterogeneity of adult-onset Still's disease: results from a multi-dimensional characterization and stratification 22
Molecular and spatial analysis of tertiary lymphoid structures in Sjogren's syndrome 21
Association Between the Use of Oral Contraceptives and the Development of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis 21
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 21
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? 21
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 21
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 21
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 21
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. 20
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 20
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 20
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease Registry 19
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 19
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 19
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 18
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 17
The Relationship Between Metabolic Syndrome and Pain Catastrophizing in Psoriatic Arthritis 16
Is minor salivary gland biopsy still mandatory in Sjogren's syndrome? Does seronegative Sjogren's syndrome exist? 16
From pain catastrophising to multidimensional psychological distress: unravelling the complexity of difficult-to-treat psoriatic arthritis 16
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 16
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features 16
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study 16
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still’s Disease Registry 16
Response to: 'Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al' by Chen et al 15
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 15
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 15
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 15
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 14
Increased Prevalence of Headaches and Migraine in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Insights from an Italian Cohort Study 14
Totale 4.241
Categoria #
all - tutte 36.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.541


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022111 0 0 2 0 0 0 0 0 18 4 5 82
2022/202398 1 2 2 4 15 1 2 8 3 5 54 1
2023/2024339 16 35 15 40 40 139 7 10 3 13 13 8
2024/20252.948 48 44 117 29 30 72 71 32 252 252 784 1.217
2025/2026807 345 144 259 59 0 0 0 0 0 0 0 0
Totale 4.303